At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 516 enrolled
Drug / intervention
AC-170 0.24% +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Multi-Center, Double-Masked, Randomized, Vehicle-Controlled, Parallel-Group Study Evaluating the Safety of AC-170 Ophthalmic Solution
In Brief
A Phase 3 clinical trial evaluating AC-170 0.24% and AC-170 Vehicle for Healthy Subjects. Completed, enrolled 516 participants across 1 site.
Detailed Summary
This is study is evaluating the safety and tolerability of AC-170 Ophthalmic Solution
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy Subjects
CountriesUnited States
CollaboratorsORA, Inc.
Timeline
Phase 3CompletedFinished
20162017201820192020202120222023202420252026
Enrollment StartApr 2016
First PostedApr 2016
Primary CompletionAug 2016
TodayJul 2026
First PostedApr 29, 2016
Enrollment StartApr 1, 2016
Primary CompletionAug 1, 2016
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 10.2 years ago
Interventions
AC-170 0.24%drug
AC-170 Vehicledrug